Senda Biosciences

Senda Biosciences company information, Employees & Contact Information

Senda Biosciences, Inc. is uniquely positioned to transform human health by harnessing millions of years of evolution to program targeted, potent and tunable medicines. Nature has provided the codes to program human cells – both within the cell (mRNA), and, remarkably, to the cell - using what surrounds it. The trillions of non-human cells in the human ecosystem have evolved natural nanoparticles that precisely shuttle biomolecules into human cells, providing the missing pieces to fully unlock programmable medicines. Senda’s proprietary platform includes the first-ever atlas of nature-derived programmable systems at the molecular level and across all kingdoms of life – accessing the entire code provided by nature required to program cells. With this platform, Senda is developing a new class of SendRNA™ medicines. The unique properties of these medicines create new frontiers for mRNA therapeutics and vaccines for infectious, genetic, autoimmune, and metabolic diseases and oncology indications – with further potential to transform the gene editing and protein-based therapy landscapes as well. Based in Cambridge, MA, Senda was founded by Flagship Pioneering.

Company Details

Employees
13
Founded
-
Address
20 Acorn Park Dr,
Email
pr****@****ces.com
Industry
Biotechnology Research
NAICS
Research and Development in Biotechnology (except Nanobiotechnology)
Keywords
Manager jobs.
HQ
Cambridge, Massachusetts
Looking for a particular Senda Biosciences employee's phone or email?

Senda Biosciences Questions

News

Senda Biosciences Announces Close of $123 Million Series C Financing - PR Newswire

Senda Biosciences Announces Close of $123 Million Series C Financing PR Newswire

Laronde, Senda Biosciences merge to create new Flagship company - BioPharma Dive

Laronde, Senda Biosciences merge to create new Flagship company BioPharma Dive

Senda Biosciences Appoints Marc Wolfgang as Senior Vice President, Manufacturing - citybiz

Senda Biosciences Appoints Marc Wolfgang as Senior Vice President, Manufacturing citybiz

Programmable medicines company Senda Biosciences closes $123M series C financing - Labiotech.eu

Programmable medicines company Senda Biosciences closes $123M series C financing Labiotech.eu

Senda Biosciences Announces Closing of $98 Million Series B Financing - PR Newswire

Senda Biosciences Announces Closing of $98 Million Series B Financing PR Newswire

Flagship brings 'intersystems biology' under one roof with Senda Biosciences - Fierce Biotech

Flagship brings 'intersystems biology' under one roof with Senda Biosciences Fierce Biotech

Flagship Pioneering’s Senda Bio secures $123M for new ‘programmable medicines’ - MedCity News

Flagship Pioneering’s Senda Bio secures $123M for new ‘programmable medicines’ MedCity News

Senda Biosciences Appoints Igor Matushansky as Chief Medical Officer - citybiz

Senda Biosciences Appoints Igor Matushansky as Chief Medical Officer citybiz

Flagship Pioneering Unveils Senda Biosciences to pioneer Intersystems Biology and create novel treatments for human disease - PR Newswire

Flagship Pioneering Unveils Senda Biosciences to pioneer Intersystems Biology and create novel treatments for human disease PR Newswire

Senda Biosciences Appoints Stuart Milstein, Ph.D., as SVP - citybiz

Senda Biosciences Appoints Stuart Milstein, Ph.D., as SVP citybiz

Top Senda Biosciences Employees

Free Chrome Extension

Find emails, phones & company data instantly

Find verified emails from LinkedIn profiles
Get direct phone numbers & mobile contacts
Access company data & employee information
Works directly on LinkedIn - no copy/paste needed
Get Chrome Extension - Free

Aero Online

Your AI prospecting assistant